曙光-话题@MedSci

#曙光#

98篇内容 | 2742人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1725196, encodeId=b3d81e2519629, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, objectTitle=NEJM：恢复期血浆治疗新冠肺炎，一波三折再现曙光！, objectType=article, longId=205728, objectId=3ca0205e284a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ca0205e284a, replyNumber=0, likeNumber=107, createdTime=2021-07-19, rootId=0, userName=yangpeizhi, userId=180c33737541, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ca0205e284a, moduleTitle=NEJM：恢复期血浆治疗新冠肺炎，一波三折再现曙光！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3ca0205e284a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725194, encodeId=22571e2519442, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, objectTitle=胃癌早诊早治工作仍需加强，免疫治疗曙光已现, objectType=article, longId=202828, objectId=0dfd2028280b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0dfd2028280b, replyNumber=0, likeNumber=103, createdTime=2021-10-06, rootId=0, userName=yangpeizhi, userId=180c33737541, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0dfd2028280b, moduleTitle=胃癌早诊早治工作仍需加强，免疫治疗曙光已现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0dfd2028280b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725186, encodeId=cfe41e251860e, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, objectTitle=**肠道选择性生物制剂安吉优®（注射用维得利珠单抗）获批进入中国，为炎症性肠病患者带来曙光, objectType=article, longId=190010, objectId=9ca0190010fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ca0190010fb, replyNumber=0, likeNumber=78, createdTime=2020-04-19, rootId=0, userName=yangpeizhi, userId=180c33737541, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ca0190010fb, moduleTitle=**肠道选择性生物制剂安吉优®（注射用维得利珠单抗）获批进入中国，为炎症性肠病患者带来曙光, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ca0190010fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725187, encodeId=3c9c1e2518717, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, objectTitle=OCC 2020 | 黄峻教授：慢性心衰药物全新作用机制展露新曙光, objectType=article, longId=195380, objectId=e206195380ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e206195380ca, replyNumber=0, likeNumber=77, createdTime=2020-09-14, rootId=0, userName=yangpeizhi, userId=180c33737541, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e206195380ca, moduleTitle=OCC 2020 | 黄峻教授：慢性心衰药物全新作用机制展露新曙光, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e206195380ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725188, encodeId=7dbb1e25188fa, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, objectTitle=近红外光免疫疗法（NIR-PIT）：治疗恶性胸膜间皮瘤的曙光, objectType=article, longId=196242, objectId=c9b419624282, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c9b419624282, replyNumber=0, likeNumber=70, createdTime=2020-12-23, rootId=0, userName=yangpeizhi, userId=180c33737541, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c9b419624282, moduleTitle=近红外光免疫疗法（NIR-PIT）：治疗恶性胸膜间皮瘤的曙光, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c9b419624282)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725191, encodeId=ae7f1e25191de, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, objectTitle=额颞痴呆治疗获迎曙光！实验性基因疗法PR006, objectType=article, longId=198206, objectId=2c871982066a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c871982066a, replyNumber=0, likeNumber=97, createdTime=2020-09-12, rootId=0, userName=yangpeizhi, userId=180c33737541, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c871982066a, moduleTitle=额颞痴呆治疗获迎曙光！实验性基因疗法PR006, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c871982066a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725184, encodeId=f23c1e25184ab, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, objectTitle=原研全人源阿达木单抗获批新适应症，为克罗恩病患者带来新的曙光!, objectType=article, longId=186386, objectId=7b2a186386f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b2a186386f6, replyNumber=0, likeNumber=74, createdTime=2020-12-29, rootId=0, userName=yangpeizhi, userId=180c33737541, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b2a186386f6, moduleTitle=原研全人源阿达木单抗获批新适应症，为克罗恩病患者带来新的曙光!, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b2a186386f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725193, encodeId=96601e25193d6, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, objectTitle=KRAS最快品种II期曙光初现，在肺癌领域显示出疗效, objectType=article, longId=201982, objectId=c13d20198295, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c13d20198295, replyNumber=0, likeNumber=72, createdTime=2021-05-22, rootId=0, userName=yangpeizhi, userId=180c33737541, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c13d20198295, moduleTitle=KRAS最快品种II期曙光初现，在肺癌领域显示出疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c13d20198295)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725185, encodeId=87091e251853e, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, objectTitle=曙光初现：阻止或减缓阿尔茨海默症状出现的药物或已问世, objectType=article, longId=187726, objectId=887518e726dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=887518e726dc, replyNumber=0, likeNumber=83, createdTime=2020-10-24, rootId=0, userName=yangpeizhi, userId=180c33737541, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=887518e726dc, moduleTitle=曙光初现：阻止或减缓阿尔茨海默症状出现的药物或已问世, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=887518e726dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725182, encodeId=559b1e251828c, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, objectTitle=Science：谷氨酰胺拮抗剂——“代谢检查点”广谱抗癌药曙光初现, objectType=article, longId=182889, objectId=966b182889aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=966b182889aa, replyNumber=0, likeNumber=87, createdTime=2020-06-21, rootId=0, userName=yangpeizhi, userId=180c33737541, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=966b182889aa, moduleTitle=Science：谷氨酰胺拮抗剂——“代谢检查点”广谱抗癌药曙光初现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=966b182889aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725189, encodeId=87c11e2518999, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, objectTitle=肾纤维化治疗的新曙光：CRV431在动物模型中展示显著疗效, objectType=article, longId=196312, objectId=97fb1963125c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97fb1963125c, replyNumber=0, likeNumber=74, createdTime=2020-11-10, rootId=0, userName=yangpeizhi, userId=180c33737541, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97fb1963125c, moduleTitle=肾纤维化治疗的新曙光：CRV431在动物模型中展示显著疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97fb1963125c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725183, encodeId=cb2e1e251836a, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, objectTitle=失眠症治疗迎来曙光：FDA已批准卫材的Dayvigo, objectType=article, longId=185145, objectId=26df1851459f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26df1851459f, replyNumber=0, likeNumber=66, createdTime=2020-06-01, rootId=0, userName=yangpeizhi, userId=180c33737541, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26df1851459f, moduleTitle=失眠症治疗迎来曙光：FDA已批准卫材的Dayvigo, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26df1851459f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725181, encodeId=78a81e25181c6, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, objectTitle=免疫治疗带来结直肠癌治疗新曙光, objectType=article, longId=182039, objectId=c92818203955, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c92818203955, replyNumber=0, likeNumber=62, createdTime=2019-12-27, rootId=0, userName=yangpeizhi, userId=180c33737541, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c92818203955, moduleTitle=免疫治疗带来结直肠癌治疗新曙光, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c92818203955)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725180, encodeId=b7c61e25180d1, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, objectTitle=“打双靶”让癌细胞无路可逃急性白血病耐药迎来新曙光, objectType=article, longId=179629, objectId=8a6d1e9629fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a6d1e9629fc, replyNumber=0, likeNumber=71, createdTime=2020-06-01, rootId=0, userName=yangpeizhi, userId=180c33737541, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a6d1e9629fc, moduleTitle=“打双靶”让癌细胞无路可逃急性白血病耐药迎来新曙光, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a6d1e9629fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725179, encodeId=bae91e251797b, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, objectTitle=GSK囊获乙肝创新疗法有望带来“功能性治愈”乙肝曙光, objectType=article, longId=178289, objectId=1f561e82897a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f561e82897a, replyNumber=0, likeNumber=86, createdTime=2020-05-18, rootId=0, userName=yangpeizhi, userId=180c33737541, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f561e82897a, moduleTitle=GSK囊获乙肝创新疗法有望带来“功能性治愈”乙肝曙光, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f561e82897a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725175, encodeId=5ac01e25175a1, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, objectTitle=樊旼教授：PACIFIC研究“海啸”袭来，III期肺癌迎接治愈曙光, objectType=article, longId=176018, objectId=5b4a1e6018c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b4a1e6018c7, replyNumber=0, likeNumber=67, createdTime=2019-09-05, rootId=0, userName=yangpeizhi, userId=180c33737541, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b4a1e6018c7, moduleTitle=樊旼教授：PACIFIC研究“海啸”袭来，III期肺癌迎接治愈曙光, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b4a1e6018c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725177, encodeId=3dad1e25177a2, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, objectTitle=PACIFIC研究“海啸”袭来，III期肺癌迎接治愈曙光, objectType=article, longId=176064, objectId=15841e606424, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15841e606424, replyNumber=0, likeNumber=73, createdTime=2020-06-27, rootId=0, userName=yangpeizhi, userId=180c33737541, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15841e606424, moduleTitle=PACIFIC研究“海啸”袭来，III期肺癌迎接治愈曙光, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15841e606424)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725170, encodeId=68681e251709a, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, objectTitle=Cell Stem Cell：“无方可治疗”的舞蹈病迎来新曙光, objectType=article, longId=157478, objectId=147415e478b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=147415e478b9, replyNumber=0, likeNumber=87, createdTime=2019-03-11, rootId=0, userName=yangpeizhi, userId=180c33737541, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=147415e478b9, moduleTitle=Cell Stem Cell：“无方可治疗”的舞蹈病迎来新曙光, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=147415e478b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725174, encodeId=c6571e25174ec, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, objectTitle=小球囊大作用│球囊肺动脉成形术：慢性血栓栓塞性肺动脉高压患者的新曙光, objectType=article, longId=175478, objectId=e9c71e5478be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9c71e5478be, replyNumber=0, likeNumber=79, createdTime=2019-10-19, rootId=0, userName=yangpeizhi, userId=180c33737541, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9c71e5478be, moduleTitle=小球囊大作用│球囊肺动脉成形术：慢性血栓栓塞性肺动脉高压患者的新曙光, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9c71e5478be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1725171, encodeId=3b391e251714f, content=<a href='/topic/show?id=58476021257' target=_blank style='color:#2F92EE;'>#曙光#</a>, objectTitle=脑癌治疗的曙光：Oncoceutics和美国国家癌症研究所合作开发ONC206 , objectType=article, longId=161248, objectId=55a316124877, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55a316124877, replyNumber=0, likeNumber=108, createdTime=2019-06-24, rootId=0, userName=yangpeizhi, userId=180c33737541, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55a316124877, moduleTitle=脑癌治疗的曙光：Oncoceutics和美国国家癌症研究所合作开发ONC206 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55a316124877)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

曙光

2020-05-29

yangpeizhi (审核中...)

前往app查看评论内容

#曙光#

NEJM：恢复期血浆治疗新冠肺炎，一波三折再现曙光！

2021-07-19

yangpeizhi (审核中...)

前往app查看评论内容

#曙光#

胃癌早诊早治工作仍需加强，免疫治疗曙光已现

2021-10-06

yangpeizhi (审核中...)

前往app查看评论内容

#曙光#

**肠道选择性生物制剂安吉优®（注射用维得利珠单抗）获批进入中国，为炎症性肠病患者带来曙光

2020-04-19

yangpeizhi (审核中...)

前往app查看评论内容

#曙光#

OCC 2020 | 黄峻教授：慢性心衰药物全新作用机制展露新曙光

2020-09-14

yangpeizhi (审核中...)

前往app查看评论内容

#曙光#

近红外光免疫疗法（NIR-PIT）：治疗恶性胸膜间皮瘤的曙光

2020-12-23

yangpeizhi (审核中...)

前往app查看评论内容

#曙光#

额颞痴呆治疗获迎曙光！实验性基因疗法PR006

2020-09-12

yangpeizhi (审核中...)

前往app查看评论内容

#曙光#

原研全人源阿达木单抗获批新适应症，为克罗恩病患者带来新的曙光!

2020-12-29

yangpeizhi (审核中...)

前往app查看评论内容

#曙光#

KRAS最快品种II期曙光初现，在肺癌领域显示出疗效

2021-05-22

yangpeizhi (审核中...)

前往app查看评论内容

#曙光#

曙光初现：阻止或减缓阿尔茨海默症状出现的药物或已问世

2020-10-24

yangpeizhi (审核中...)

前往app查看评论内容

#曙光#

Science：谷氨酰胺拮抗剂——“代谢检查点”广谱抗癌药曙光初现

2020-06-21

yangpeizhi (审核中...)

前往app查看评论内容

#曙光#

肾纤维化治疗的新曙光：CRV431在动物模型中展示显著疗效

2020-11-10

yangpeizhi (审核中...)

前往app查看评论内容

#曙光#

失眠症治疗迎来曙光：FDA已批准卫材的Dayvigo

2020-06-01

yangpeizhi (审核中...)

前往app查看评论内容

#曙光#

免疫治疗带来结直肠癌治疗新曙光

2019-12-27

yangpeizhi (审核中...)

前往app查看评论内容

#曙光#

“打双靶”让癌细胞无路可逃急性白血病耐药迎来新曙光

2020-06-01

yangpeizhi (审核中...)

前往app查看评论内容

#曙光#

GSK囊获乙肝创新疗法有望带来“功能性治愈”乙肝曙光

2020-05-18

yangpeizhi (审核中...)

前往app查看评论内容

#曙光#

樊旼教授：PACIFIC研究“海啸”袭来，III期肺癌迎接治愈曙光

2019-09-05

yangpeizhi (审核中...)

前往app查看评论内容

#曙光#

PACIFIC研究“海啸”袭来，III期肺癌迎接治愈曙光

2020-06-27

yangpeizhi (审核中...)

前往app查看评论内容

#曙光#

Cell Stem Cell：“无方可治疗”的舞蹈病迎来新曙光

2019-03-11

yangpeizhi (审核中...)

前往app查看评论内容

#曙光#

小球囊大作用│球囊肺动脉成形术：慢性血栓栓塞性肺动脉高压患者的新曙光

2019-10-19

yangpeizhi (审核中...)

前往app查看评论内容

#曙光#

脑癌治疗的曙光：Oncoceutics和美国国家癌症研究所合作开发ONC206 

2019-06-24

科室
- - 订阅+
  - 更多科室
工具
服务